How procurement judges the value of medical technologies: a review of health care tenders

8 February 2019 - Procurement's important role in healthcare decision making has encouraged criticism and calls for greater collaboration with health ...

Read more →

Notice of information: No further RFPs to be released by PHARMAC in 2018

21 November 2018 - PHARMAC will not be releasing any further requests for proposals in 2018. ...

Read more →

Request for proposals - supply of various vaccines and influenza vaccines

20 November 2018 - PHARMAC invites proposals for the supply of various vaccines and influenza vaccines in New Zealand. ...

Read more →

RFP - supply of etanercept

5 November 2018 - PHARMAC invites proposals for the supply of etanercept in New Zealand. ...

Read more →

Request for proposals for PHARMAC and HRC research partnership 2019

8 October 2018 - PHARMAC and the Health Research Council of New Zealand request research proposals. ...

Read more →

Declining HIV numbers bolstered by new prevention drug but more data needed

13 August 2018 - PHARMAC's decision earlier this year to fund anti-retroviral drug Truvada as a preventive treatment was hailed ...

Read more →

Supply of anti-retroviral treatments

6 August 2018 - PHARMAC invites tenders for the supply of certain antiretroviral treatments to DHB hospitals and to community pharmacies ...

Read more →

RFP - supply of recombinant factor VIII, recombinant factor IX and bypassing agents for the treatment of haemophilia

23 July 2018 - PHARMAC invites proposals for the supply of Recombinant Factor VIII, Recombinant Factor IX and bypassing agents (Recombinant ...

Read more →

Call for funding applications for medicines for rare disorders

28 June 2018 - PHARMAC invites pharmaceutical suppliers to submit funding applications for medicines for rare disorders. ...

Read more →

Advance notice of a request for proposals - permanent coronary drug-eluting stents

29 September 2017 - PHARMAC is interested in receiving proposals for dual and/or sole supply market share of permanent coronary ...

Read more →

RFP - supply of a first line enzyme replacement therapy for the treatment of Gaucher disease

7 August 2017 - PHARMAC invites proposals for the supply of a first line enzyme replacement therapy for the treatment ...

Read more →

Roche invited to submit a CDF proposal for urothelial cancer drug

 2 August 2017 - NICE has asked Roche to submit a Cancer Drugs Fund proposal for an immunotherapy treatment called ...

Read more →

RFP - supply of entecavir and tenofovir disoproxil tablets or capsules

19 July 2017 - PHARMAC invites proposals for the supply of entecavir and tenofovir disoproxil in New Zealand. ...

Read more →

Request for supply - supply of nicotine replacement therapy

20 February 2017 - PHARMAC invites proposals for the supply of nicotine replacement therapy (NRT) - including, but not limited to, ...

Read more →

Decision relating to nicotine replacement therapy RFP

8 February 2017 - PHARMAC has decided to not accept any proposal in response to, and to terminate the process ...

Read more →